Skip to main content

Affinity Asset Advisors, LLC

Position in NRIX — Nurix Therapeutics, Inc.

CIK 1773195 NEW YORK, NY

Position in NRIX

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$23,474,461
+$8,476,351 QoQ
Shares Held
967,620
0.0% QoQ
Ownership
0.932%
of shares outstanding
% of Portfolio
1.18%
of 13F equity value
Holder Rank
#29
of 210 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NRIX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Affinity Asset Advisors, LLC holds $1,842,784,374 across 87 Biotechnology names. NRIX ranks #24 (1.3% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in NRIX

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $23,474,461 967,620
2026-03-31 $14,998,110 967,620
2025-12-31 $18,355,751 967,620
2025-09-30 $8,940,808 967,620
2025-06-30 $11,021,191 967,620
2025-03-31 $9,630,747 810,669
2024-12-31 $17,711,163 940,083
2024-09-30 $19,333,165 860,399
2024-06-30 $19,033,440 912,000
2024-03-31 $11,910,719 810,253
2023-12-31 $7,121,955 690,112
2023-09-30 $1,965,000 250,000
2023-06-30 $999,000 100,000
2023-03-31 $1,332,000 150,000
2022-12-31 $878,400 80,000